Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-15-046403
Filing Date
2015-08-05
Accepted
2015-08-05 12:03:09
Documents
10
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q v416467_10q.htm 10-Q 353727
2 EXHIBIT 31.1 v416467_ex31-1.htm EX-31.1 9462
3 EXHIBIT 31.2 v416467_ex31-2.htm EX-31.2 9657
4 EXHIBIT 32.1 v416467_ex32-1.htm EX-32.1 5886
  Complete submission text file 0001144204-15-046403.txt   4025083

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT ecyt-20150630.xml EX-101.INS 1115643
6 XBRL TAXONOMY EXTENSION SCHEMA ecyt-20150630.xsd EX-101.SCH 27557
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ecyt-20150630_cal.xml EX-101.CAL 28131
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ecyt-20150630_def.xml EX-101.DEF 183248
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ecyt-20150630_lab.xml EX-101.LAB 258614
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ecyt-20150630_pre.xml EX-101.PRE 222644
Mailing Address 3000 KENT AVE STE A1-100 WEST LAFAYETTE IN 47906
Business Address 3000 KENT AVE STE A1-100 WEST LAFAYETTE IN 47906 7654637175
ENDOCYTE INC (Filer) CIK: 0001235007 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35050 | Film No.: 151028119
SIC: 2834 Pharmaceutical Preparations